TrialMalaria journal2009

Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12-24 months.

John P A Lusingu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.